secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001558370-24-009401
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

NextCure shareholders reject officer exculpation amendment at 2024 annual meeting
--------------------------------------------------------------------------------

- Proposal to amend charter to exculpate officers failed: 10,638,433 for, 2,863,486 against, 11,212 abstain.
- Elaine V. Jones and Ellen G. Feigal elected as Class II directors with 11.8M and 12.9M votes for, respectively.
- Ernst & Young LLP ratified as independent auditor for FY2024: 21,818,499 for, 98,189 against.
- Broker non-votes of 8,403,929 on director election and exculpation proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000155837024009401/0001558370-24-009401-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000155837024009401/nxtc-20240620x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009401

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer